---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-050758"
form_type: "8-K"
ticker: "COCH"
cik: "0001840877"
company_name: "Envoy Medical, Inc."
filed_at: "2025-06-03T23:59:59+00:00"
generated_at: "2026-05-20T01:52:47.056272+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Stockholders approve amendment to 2023 Equity Incentive Plan, releasing 1.5M restricted shares

## Summary
- Amendment removes regulatory-milestone restriction on 1,500,000 shares, making them available for issuance under the 2023 Plan.
- Vote: 12,332,451 For, 658,102 Against, 20,782 Abstain, 29,189 Broker Non-Votes; amendment effective immediately.
- Elected directors Janis Smith-Gomez (12,636,087 For) and Chuck Brynelsen (12,307,953 For) to Class II, term until 2028 annual meeting.
- Ratified Grant Thornton LLP as independent auditor for FY2025; approved non-binding advisory vote on named executive officer compensation.

## SEC filing metadata
- accession: 0001213900-25-050758
- form_type: 8-K
- ticker: COCH
- cik: 0001840877
- company_name: Envoy Medical, Inc.
- filed_at: 2025-06-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840877/000121390025050758/0001213900-25-050758-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840877/000121390025050758/ea0244418-8k_envoy.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-050758
- JSON: https://secwatch.observer/filing/0001213900-25-050758.json
- Plain text: https://secwatch.observer/filing/0001213900-25-050758.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.